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Another Human Case of Equine
Morbillivirus Disease in Australia
Another human case of equine morbillivirus
(EMV) disease has occurred in Australia. The pa-
tient was a 35-year-old farmer, who lived near
Mackay, in northern Queensland. He died in the
Royal Brisbane Hospital on October 21, 1995 (1).
The patient was probably infected with the novel
virus 12 months before his death—approximately
the time of the first reported outbreak of EMV.
A hitherto unknown infectious disease, EMV
was first observed in Brisbane, Queensland, in
September 1994, when an outbreak of acute res-
piratory disease in horses at three stables in Hen-
dra, a Brisbane suburb, was reported (2). In a
2-week period, 14 racehorses and two persons at
the stable contracted the disease. One of the hu-
man cases and some of the equine cases were fatal.
A total of 21 horses were infected with the virus.
Fourteen horses died as a result of clinical illness
(they either died from the infection or were
euthanized). The remaining horses had either
symptomatic or asymptomatic infection and were
euthanized.
The cause of infection in the recent case has
been confirmed as EMV at the Australian Animal
Health Laboratory in Geelong through the testing
of samples taken from the patient before he died
(I. Douglas, Australian Communicable Disease
Service; PROMED).
The Mackay patient was married to a veteri-
nary surgeon. The couple bred horses and grew
sugar cane. In August 1994 (a month before the
outbreak of EMV in southern Queensland), two
horses died on the couple’s property. The veteri-
nary surgeon, assisted by her husband, performed
autopsies on the two animals. The diagnoses,
based on these autopsies, were “avocado poison-
ing” and “brown snake bite,” respectively (1).
In August-September 1994, soon after the
death of the horses, the husband became ill with
a mild meningoencephalitis, which improved with
antibiotics. Cerebrospinal fluid examination
showed a neutrophilic pleocytosis suggestive of a
viral infection (1). Serum collected at the time of
the examination and stored was found to contain
a low but significant titer of antibody to EMV.
The patient appeared to have recovered; how-
ever, he was admitted to the hospital 5 weeks
before his death with signs of encephalitis.
Evidence of EMV infection included a high serum
neutralizing antibody titer against the virus and
a positive polymerase chain reaction (PCR) test of
cerebrospinal fluid collected before his death.
Tests of autopsy specimens confirmed the
infection.
Direct fluorescence antibody and PCR tests of
fixed tissue blocks from one of the horses at the
Australian Animal Health Laboratory have con-
firmed that it was infected with EMV (I. Douglas,
PROMED). However, it is likely that both horses
were infected.
The Mackay patient’s symptoms were predomi-
nantly neurologic. He displayed no respiratory
symptoms until aspiration pneumonia  developed.
By contrast, the major clinical symptoms of EMV
in Hendra were respiratory.
No recent outbreaks of clinical illness have been
reported in the horses on the Mackay property—or
elsewhere in Queensland—since the 1994 out-
break. Also, investigation has not shown a link
between the horses on the Mackay property and
those in the Hendra stables. A serologic survey of
over 2,000 horses, undertaken in 1994 after the
Hendra outbreak, yielded negative results. That
survey included more than 200 horses in the
Mackay/Rockhampton/Townsville areas. Simi-
larly, the Queensland veterinary authorities  have
obtained samples from more than 3,000 animals
from 294 populations (including farms, race meet-
ings, and horse events) since October 23, 1995;
2,349 of the samples have been tested, all with
negative results. Moreover, blood samples re-
cently taken from all the domestic animals on the
Mackay property, including approximately 90
horses, have been tested for virus by the Animal
Health Bureau, Queensland Department of Pri-
mary Industry and Energy. All results were
negative.
An extensive epidemiologic investigation is be-
ing conducted by the Queensland Department of
Health and the Department of Primary Industry
and Energy. All persons who may have had expo-
sure to the virus in either episode have been tested
for EMV infection and had negative results (1). No
serologic evidence of further human infection has
been found.
No human-to-human transmission of EMV has
been reported. It is believed that the disease is
spread through contact with the body fluids of
infected sick or dying animals.
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Social Science and the Study of
Emerging Infectious Diseases
Topics related to emerging and reemerging in-
fectious diseases attracted a considerable audi-
ence at the annual meeting of the American
Anthropological Association, November 15–19,
1995, in Washington, D.C. The meeting had a
separate session entitled “Emerging and Ree-
merging Infectious Diseases: Biocultural and So-
ciocultural Approaches.”
The session brought together anthropologists
interested in and working on emerging infectious
diseases from various subdisciplinary perspec-
tives. Presentations were made on the following
subjects: outline of a research agenda, deforesta-
tion and the emergence of infectious diseases in
the rain forests of Papua-New Guinea, the cholera
epidemic in Latin America, evolutionary aspects
of emergent infections, societal impacts of the test
for acquired immunodeficiency syndrome, compli-
ance and iatrogenesis in tuberculosis treatment in
the United States, patchwork policies that affect
long-term treatment of tuberculosis in Nepal and
Uganda, the reemergence of schistosomiasis in
Egypt, dengue control in Latin America, cultural
and political ecologic models of emergent infec-
tions, and the politics of leprosy eradication. Ab-
stracts are available from the conference
organizers, listed below.
Anthropologists interested in international
health and the social science aspects of infectious
diseases are organized in a working group called
the International Health and Infectious Disease
Study Group of the Society of Medical Anthropol-
ogy (American Anthropological Association). Re-
quests to subscribe to this group’s newsletter can
be sent to
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WHO Establishes New
Rapid-Response Unit for Emerging
Infectious Diseases
The World Health Organization (WHO) has
established a new rapid-response unit to control
and prevent the growing incidence of new and
reemerging diseases worldwide. The unit’s focus
will be improved containment of disease out-
breaks, such as that caused by the deadly Ebola
virus, which struck Zaire in 1995.
The WHO unit will be called the Division of
Emerging Viral and Bacterial Diseases Surveil-
lance and Control (EMC). It will be capable of
mobilizing staff from WHO headquarters in Ge-
neva and from the organization’s regional offices.
In addition to mobilizing WHO’s own technical
staff and expertise, EMC will coordinate the ac-
tivities of the agency’s traditional partners, for
example, its international network of collaborat-
ing centers, bilateral donors, expert advisers, and
nongovernmental organizations.
Teams equipped to implement epidemic control
measures will be placed on-site within 24 hours’
notification of an outbreak. This strategy, when
implemented in Zaire, not only rapidly contained
the recent Ebola outbreak but also prevented its
spread to Kinshasa, the capital city of 2 million.
Among EMC’s goals are 1) to strengthen local
surveillance and disease control so that countries
can develop the early warning systems needed to
detect emerging or reemerging diseases through
innovative field epidemiology and public health
laboratory training programs and 2) to continue
WHO’s activities in developing a network of public
health laboratories to strengthen regional and
international collaboration in outbreak detection
and control.
EMC will continue to expand WHO’s network—
termed WHONET—that detects and monitors an-
tibiotic resistance worldwide. WHO will use the
information collected to continue to advocate
research and development of new antibiotics to
replace those that are no longer effective.
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